Other
Neoplasm by Morphology
CI-CAN-00000002Explore in graph →
Non-malignant13,319 active trials222 approved drugs2,774 evidence items
- NCIt
- C4741
Loading cancer entity…
Loading cancer entity…
Other
CI-CAN-00000002Explore in graph →
Clinical trials
52,657 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00083239 | Study of Talabostat in Advanced Melanoma | completed | Phase 2 | — | Point TherapeuticsINDUSTRY | 1 | Jun 8, 2007 | clinicaltrials |
| NCT00083252 | Study of Talabostat and Cisplatin in Advanced Melanoma | completed | Phase 2 | — | Point TherapeuticsINDUSTRY | 1 | Jun 8, 2007 | clinicaltrials |
| NCT00483132 |
| Study of Treatment High Risk and/or Low Risk Acute Lymphoblastic leukémia(ALL) Adults Stage III |
| completed |
| Phase 3 |
| 232 |
| French Innovative Leukemia OrganisationOTHER |
| 1 |
| Jun 6, 2007 |
| clinicaltrials |
| NCT00481299 | Insulin Resistance in Women With Prolactinoma | completed | — | 2,004 | Universidade Federal do Rio de JaneiroOTHER | 1 | Jun 1, 2007 | clinicaltrials |
| NCT00480064 | Lomustine and Intermediate Dose Cytarabine in Older Patients With AML | completed | Phase 3 | 360 | French Innovative Leukemia OrganisationOTHER | 1 | May 30, 2007 | clinicaltrials |
| NCT00479375 | Randomized Controlled Trial of Human Papillomavirus Testing in Primary Cervical Cancer Screening(SWEDESCREEN) | completed | N/A | 12,527 | Skane University HospitalOTHER | 1 | May 28, 2007 | clinicaltrials |
| NCT00479050 | Combination Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Greater Than 3 cm(TACE-RFA) | completed | Phase 1 | 291 | Shandong UniversityOTHER | 0 | May 25, 2007 | clinicaltrials |
| NCT00192049 | A Randomized Study Comparing Single Agent Gemcitabine Intravesical Therapy Versus Mitomycin C in Patients With Intermediate Risk Superficial Bladder Cancer | completed | Phase 2 | 90 | Eli Lilly and CompanyINDUSTRY | 1 | May 17, 2007 | clinicaltrials |
| NCT00086034 | Study of Motexafin Gadolinium for the Treatment of Non-Hodgkin's Lymphoma | completed | Phase 2 | 35 | Pharmacyclics LLC.INDUSTRY | 1 | May 15, 2007 | clinicaltrials |
| NCT00054795 | Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART) | completed | Phase 3 | 550 | Pharmacyclics LLC.INDUSTRY | 8 | May 8, 2007 | clinicaltrials |
| NCT00066885 | Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 80 | NovaceaINDUSTRY | 1 | May 7, 2007 | clinicaltrials |
| NCT00034827 | A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer | completed | Phase 2 | 172 | PfizerINDUSTRY | 1 | May 4, 2007 | clinicaltrials |
| NCT00039910 | Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia | completed | Phase 3 | 240 | PfizerINDUSTRY | 8 | May 4, 2007 | clinicaltrials |
| NCT00105092 | Enzastaurin as Second and Third-Line Treatment for Non-Small Cell Lung Cancer. | completed | Phase 2 | 50 | Eli Lilly and CompanyINDUSTRY | 1 | May 1, 2007 | clinicaltrials |
| NCT00299780 | Safety Study of Parathyroid Hormone in Patients Needing Additional Stem Cell Mobilization. | completed | Phase 1 | 12 | Massachusetts General HospitalOTHER | 1 | Apr 24, 2007 | clinicaltrials |
| NCT00188461 | Dose Reduction in Thoracic CT | completed | Phase 1 | 100 | University Health Network, TorontoOTHER | 1 | Apr 23, 2007 | clinicaltrials |
| NCT00464282 | Fluorine-18-α-Methyltyrosine Positron Emission Tomography for Diagnosis and Staging of Lung Cancer | completed | — | — | Gunma UniversityOTHER | 0 | Apr 23, 2007 | clinicaltrials |
| NCT00204607 | Intradermal Vaccination With Stabilized Tumor mRNA - a Clinical Phase I/II Trial in Melanoma Patients | completed | Phase 1 / Phase 2 | 20 | University Hospital TuebingenOTHER | 1 | Apr 19, 2007 | clinicaltrials |
| NCT00089596 | Infusion of Specially Treated Umbilical Cord Stem Cells After Chemoradiation Treatment for Blood Cancers | completed | Phase 1 / Phase 2 | 10 | ViaCellINDUSTRY | 1 | Apr 12, 2007 | clinicaltrials |
| NCT00386815 | Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma | completed | Phase 2 | 20 | Eli Lilly and CompanyINDUSTRY | 1 | Apr 11, 2007 | clinicaltrials |
| NCT00330538 | Osteoporosis in Children With ALL | completed | — | 20 | Children's Mercy Hospital Kansas CityOTHER | 1 | Apr 6, 2007 | clinicaltrials |
| NCT00076609 | Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 31 | PhytoCeuticaINDUSTRY | 2 | Mar 28, 2007 | clinicaltrials |
| NCT00161668 | Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care | completed | — | 500 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Mar 15, 2007 | clinicaltrials |
| NCT00134186 | Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) Cancer | completed | Phase 2 | 43 | Pharmacyclics LLC.INDUSTRY | 1 | Mar 5, 2007 | clinicaltrials |
| NCT00441662 | Sub-Tenon Triamcinolone in the Prevention of Radiation-Induced Macular Edema | completed | N/A | 170 | Wills EyeOTHER | 1 | Mar 1, 2007 | clinicaltrials |
| NCT00439127 | OnT4-Thyroglobulin Assay Before rhTSH-Aided Radioiodine Ablation | completed | — | 28 | Oncology Institute of Southern SwitzerlandOTHER | 0 | Feb 28, 2007 | clinicaltrials |
| NCT00067249 | Women's Use of Alternative Medicine: A Multiethnic Study | completed | — | 3,200 | National Center for Complementary and Integrative Health (NCCIH)NIH | 0 | Feb 27, 2007 | clinicaltrials |
| NCT00273884 | Amonafide in Combination With Cytarabine in Secondary AML | completed | Phase 2 | 80 | Xanthus Pharmaceuticals, Inc.INDUSTRY | 2 | Feb 19, 2007 | clinicaltrials |
| NCT00430911 | Radiotherapy for Malignant Astrocytomas in the Elderly | completed | Phase 3 | — | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Feb 2, 2007 | clinicaltrials |
| NCT00061464 | Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy. | completed | Phase 2 | 48 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00061477 | Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma | completed | Phase 2 | 48 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00190723 | A Study of LY317615 in Patients With Brain Tumors | completed | Phase 2 | 120 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00190762 | A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of Mesothelioma | completed | Phase 3 | 240 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00190840 | A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 186 | Eli Lilly and CompanyINDUSTRY | 8 | Jan 26, 2007 | clinicaltrials |
| NCT00191230 | Gemcitabine/Platinum Containing Regimens as Preoperative Chemotherapy for Patients With Non Small Cell Lung Cancer | completed | Phase 2 | 70 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00191256 | Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung Cancer | completed | Phase 2 | 77 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00191490 | A Randomized Study Evaluating the Feasibility and Activity of Three Different Combination With Gemcitabine as First Line Therapy for Non Small Cell Lung Cancer | completed | Phase 2 | 162 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00191503 | Gemcitabine and Pemetrexed in Primary Unknown Adenocarcinoma | completed | Phase 2 | 30 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00191620 | Study Comparing Short Infusion Vs. Fixed Dose of Cisplatin + Gemcitabine in Non Small Cell Lung Cancer. | completed | Phase 2 | 64 | Eli Lilly and CompanyINDUSTRY | 4 | Jan 26, 2007 | clinicaltrials |
| NCT00191711 | Intravesical Gemcitabine Instillation Followed by Transurethral Resection for the Treatment of Patients With Superficial Bladder Cancer at Low Risk. | completed | Phase 2 | 43 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00191750 | A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returned | completed | Phase 2 | 80 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00192088 | A Study of Pemetrexed Plus Oxaliplatin as First Line Therapy in Advanced Gastric Carcinoma | completed | Phase 2 | 43 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00260026 | Safety and Pharmacokinetics of Jin Fu Kang in Comb w/Docetaxel for Patients w/Non-Small Cell Lung Cancer | completed | Phase 2 | 20 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00074646 | Phase I Trial of CC-8490 for the Treatment of Subjects With Recurrent/Refractory High-Grade Gliomas | completed | Phase 1 | 36 | Celgene CorporationINDUSTRY | 1 | Jan 4, 2007 | clinicaltrials |
| NCT00376883 | Pamidronate Prophylaxis in Multiple Myeloma 30 mg/Month Versus 90 mg/Month | completed | Phase 3 | 500 | Nordic Myeloma Study GroupOTHER | 3 | Jan 4, 2007 | clinicaltrials |
| NCT00179686 | A Study to Evaluate the Single-Agent Lenalidomide in Subjects With Recurrent Non-Small-Cell Lung Cancer | completed | Phase 2 | 40 | Celgene CorporationINDUSTRY | 1 | Dec 20, 2006 | clinicaltrials |
| NCT00399867 | Simvastatin as Inhibitor of Cell Adhesion Mediated Drug Resistance in Patients With Refractory Multiple Myeloma. | completed | Phase 2 | 30 | Ludwig-Maximilians - University of MunichOTHER | 0 | Dec 20, 2006 | clinicaltrials |
| NCT00411541 | Pulses of Vincristine and Dexamethasone in BFM Protocols for Children With Acute Lymphoblastic Leukemia | completed | Phase 4 | 2,600 | International BFM Study GroupNETWORK | 8 | Dec 14, 2006 | clinicaltrials |
| NCT00358020 | Melphalan, Prednisone, Thalidomide And Bortezomib In Advanced And Refractory Multiple Myeloma Patients | completed | Phase 2 | 30 | University of Turin, ItalyOTHER | 1 | Dec 4, 2006 | clinicaltrials |
| NCT00407264 | Randomized Trial of Fluticasone in Bronchial Premalignancy | completed | Phase 2 | 90 | Amsterdam UMC, location VUmcOTHER | 1 | Dec 4, 2006 | clinicaltrials |
Data updated 23 days agoSource updated Jun 8, 2007source: clinicaltrials